Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 199.35 Million | 119.69 Million | 70.91 Million | 58.4 Million | 262 Million | 263.1 Million |
| Net Income | 187.57 Million | 123.89 Million | 167.44 Million | 183.35 Million | 266.08 Million | 263.92 Million |
| Depreciation & Amortization | 42.93 Million | 38.71 Million | 36.14 Million | 30.03 Million | 34.66 Million | 34.55 Million |
| Deferred income taxes | -33.02 Million | -3.15 Million | 825.6 Thousand | -33.05 Million | -4.42 Million | -122.93 Thousand |
| Stock-based compensation | 9.7 Million | 7.29 Million | 7.29 Million | 1.21 Million | - | - |
| Change in working capital | -69.35 Million | -57.84 Million | -98.79 Million | -134.91 Million | -37.93 Million | -30.24 Million |
| Other non-cash items | 4.97 Million | 10.78 Million | -41.99 Million | 11.77 Million | -796.49 Thousand | -5.13 Million |
| Investing Cash Flow | -447.71 Million | -324.5 Million | -642.44 Million | -420.83 Million | -303.69 Million | -7.37 Million |
| Investments in PPE | -100.91 Million | -96.31 Million | -164.65 Million | -50.37 Million | -18.88 Million | -16.84 Million |
| Acquisitions | 14.6 Thousand | 500.00 | -360 Million | -540 Million | 18.92 Million | 16.84 Million |
| Investment purchases | -1.69 Billion | -630.73 Million | -687.95 Million | -1.23 Billion | -553.67 Million | -8.15 Million |
| Sales/Maturities of investments | 1.34 Billion | 387.3 Million | 584.8 Million | 1.4 Billion | 268.83 Million | 17.62 Million |
| Other Investing Activities | 2.72 Million | 15.22 Million | -14.65 Million | -617.99 Thousand | -18.88 Million | -16.84 Million |
| Financing Cash Flow | 143.62 Million | -56.89 Million | 57.75 Million | -93.04 Million | -80 Million | 891.34 Million |
| Debt repayment | -145.67 Million | -9.94 Million | -27.42 Million | -24.95 Million | - | - |
| Dividends payments | -31.29 Million | -46.94 Million | -55.18 Million | -80 Million | -80 Million | - |
| Common Stock Repurchased | -26.18 Thousand | - | -124.64 Million | -74.51 Million | - | - |
| Common Stock Issuance | 42.4 Million | - | -816.54 Thousand | 62.91 Million | - | - |
| Other Financing Activities | 32.89 Million | -0.24 | 266.24 Million | 23.5 Million | - | 891.34 Million |
| Accounts receivables | -35.73 Million | -64.93 Million | -22.56 Million | 42.05 Million | -42.59 Million | -170.59 Million |
| Accounts payables | 10.88 Million | 713.52 Thousand | -63.98 Million | -124.22 Million | 13.7 Million | 132.87 Million |
| Inventory | -11.47 Million | 9.53 Million | -13.07 Million | -19.68 Million | -4.62 Million | 7.59 Million |
| Other working capital | 18.61 Million | -3.15 Million | 825.6 Thousand | -33.05 Million | -4.42 Million | -37.83 Million |
| Cash at beginning of period | 333.32 Million | 595.78 Million | 1.1 Billion | 1.56 Billion | 1.68 Billion | 539.79 Million |
| Cash at end of period | 227.22 Million | 333.32 Million | 595.78 Million | 1.1 Billion | 1.56 Billion | 1.68 Billion |
| Capital Expenditure | -100.91 Million | -96.31 Million | -164.65 Million | -50.37 Million | -18.88 Million | -16.84 Million |
| Effect of forex changes on cash | -1.36 Million | -751.99 Thousand | -153.7 Thousand | -216.28 | 0.66 | 0.18 |
| Net cash flow / Change in cash | -106.1 Million | -262.46 Million | -513.93 Million | -455.47 Million | -121.68 Million | 1.14 Billion |
| Free Cash Flow | 98.44 Million | 23.37 Million | -93.73 Million | 8.03 Million | 243.11 Million | 246.26 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.77 Million | 37.54 Million | 41.65 Million | 1.81 Million | 187.57 Million | 55.74 Million |
| Depreciation & Amortization | - | 9.68 Million | 9.68 Million | 42.93 Million | 42.93 Million | -21.2 Million |
| Deferred income taxes | - | - | - | - | -33.02 Million | - |
| Stock-based compensation | - | 10.55 Million | - | 9.7 Million | 9.7 Million | - |
| Change in working capital | - | -7.13 Million | - | -28.59 Million | -69.35 Million | 71.46 Million |
| Other non-cash items | -2.74 Million | 20.77 Million | 3.37 Million | -1.81 Million | 4.97 Million | -3.55 Million |
| Investing Cash Flow | -5.57 Million | -54.44 Million | 14.5 Million | -172.77 Million | -447.71 Million | 25.81 Million |
| Investments in PPE | -37.09 Million | -14.44 Million | -15.12 Million | -49.45 Million | -100.91 Million | -26.75 Million |
| Acquisitions | 27.58 Thousand | - | - | 13 Thousand | 14.6 Thousand | 1600.00 |
| Investment purchases | -320 Million | -390 Million | -220 Million | -415.5 Million | -1.69 Billion | -90 Million |
| Sales/Maturities of investments | 351.5 Million | 350 Million | 249.62 Million | 292.16 Million | 1.34 Billion | 142.56 Million |
| Other Investing Activities | - | -28.44 Million | 29.62 Million | -123.32 Million | 2.72 Million | -0.05 |
| Financing Cash Flow | 5.54 Million | -26.75 Million | 25.08 Million | 6.04 Million | 143.62 Million | 34.44 Million |
| Debt repayment | -47.53 Million | -23.47 Million | -28.12 Million | -10.97 Million | -145.67 Million | -1.68 Million |
| Dividends payments | - | -1.33 Million | -1.34 Million | -1.74 Million | -31.29 Million | -32.88 Million |
| Common Stock Repurchased | - | - | - | -26.18 Thousand | -26.18 Thousand | - |
| Common Stock Issuance | - | - | - | 42.4 Million | 42.4 Million | - |
| Other Financing Activities | -41.99 Million | 360.99 Thousand | -1.69 Million | -3.17 Million | 32.89 Million | 69.01 Million |
| Accounts receivables | - | 4.92 Million | - | -35.73 Million | -35.73 Million | 68.32 Million |
| Accounts payables | - | - | - | - | 10.88 Million | -2.92 Million |
| Inventory | - | -23.75 Million | - | -11.47 Million | -11.47 Million | 3.13 Million |
| Other working capital | - | 11.69 Million | - | 18.61 Million | 18.61 Million | 2.92 Million |
| Cash at beginning of period | 277.33 Million | 314.2 Million | 227.22 Million | 341.59 Million | 333.32 Million | 179.17 Million |
| Cash at end of period | 307.75 Million | 277.33 Million | 311.21 Million | 227.22 Million | 227.22 Million | 341.59 Million |
| Capital Expenditure | -37.09 Million | -14.44 Million | -15.12 Million | -49.45 Million | -100.91 Million | -26.75 Million |
| Effect of forex changes on cash | - | -1.33 Million | -621.99 Thousand | -606.72 Thousand | -1.36 Million | -286.32 Thousand |
| Net cash flow / Change in cash | 30.42 Million | -36.87 Million | 83.99 Million | -114.37 Million | -106.1 Million | 162.41 Million |
| Free Cash Flow | -6.07 Million | 34.2 Million | 29.9 Million | 3.5 Million | 98.44 Million | 75.69 Million |
VMC
605080
7314
KALYANI
ALLUX
DWVYF